9 | $MTTR 25% v9,0M c2.67 f301,235M Hod2.68 ML1.84=LL | znewcar1 | 11/07/2023 9:45:22 PM |
8 | $MTTR gaps down Lod3.05 now back | znewcar1 | 08/08/2023 3:52:12 PM |
7 | $MTTR lod3.11 Tapping3.2 | znewcar1 | 08/07/2023 11:57:43 AM |
6 | $MTTR Hod3.78 F295,867M an increase of 12M LL2.2M | znewcar1 | 07/16/2023 12:21:39 PM |
5 | $MTTR 24% v21,6M c3.77 f283,7M H3.90 | znewcar1 | 11/11/2022 5:49:52 PM |
4 | 4 STOCKS UNDER $10 WITH MASSIVE UPSIDE POTENTIAL! | AviseAnalytics | 02/14/2022 8:43:27 AM |
3 | MTTR 21% v18,7M c33.05 f242M | znewcar1 | 11/29/2021 4:27:20 PM |
2 | MTTR 22% v17,1M c27.12 f242M | znewcar1 | 11/15/2021 6:29:18 PM |
1 | MTTR 18% v12,8M c22.45 f241M | znewcar1 | 10/29/2021 10:58:39 PM |
Recent Articles
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
- Transforming Assets: The Role of NB HASH in Digital Wealth
- The Future of Wealth: Bridging Real-World Assets with Blockchain
- Avacta Therapeutics Reveals Promising Phase 1a Results for FAP-Dox
- Significant Phase 1a Trial Findings for Faridoxorubicin
- Major Developments in AI: Insights from Top Tech Executives
- Celebrating Five Years of Innovations at United Imaging's Hub
- International Engagement Highlighted at Financial Forum 2025
- Crypto World Buzzes: Ripple's Fund, Bitcoin's Future & More
- Max Stock Limited Reveals Holdings of Key Parties and Officers
- China's Revolutionary Advances in Solid-State Battery Tech
- Biggest Weekly Losers: Insights on IonQ and Tempus AI Stocks
- Revolutionizing Startup Insight with AI: Startuprad.io's New Tool
- Revolutionizing Patient Care with AI: HDAI's Innovative Approach
- Top Gainers in the Market: D-Wave, Estée Lauder & Others
- Empowering Higher Education Payroll Professionals at EIPC
- SystImmune's Iza-bren Shows Promising Results in Cancer Trial
- Latest Developments in the Auto Industry and Technology Advancements
- RAPT Therapeutics Set to Unveil Key Clinical Findings Soon
- Tech Industry Update: Innovations, Earnings, and Future Trends
- Mutuum Finance Advances Plans for Testnet Launch in 2025
- Replimune Showcases Promising Results for Acral Melanoma
- Exciting Developments in RAPT Therapeutics' Clinical Trials
- Are Aliens Now More Likely Than Bitcoin Reaching $200,000?
- Apple's New F1 Streaming Deal and Exciting Recent Developments